nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—ABCB1—Ezetimibe—atherosclerosis	0.0779	0.152	CbGbCtD
Flurazepam—ABCB1—Simvastatin—atherosclerosis	0.0725	0.141	CbGbCtD
Flurazepam—ABCB1—Pravastatin—atherosclerosis	0.0709	0.138	CbGbCtD
Flurazepam—ABCB1—Lovastatin—atherosclerosis	0.0709	0.138	CbGbCtD
Flurazepam—CYP3A4—Ezetimibe—atherosclerosis	0.0467	0.0909	CbGbCtD
Flurazepam—CYP3A4—Rosuvastatin—atherosclerosis	0.0467	0.0909	CbGbCtD
Flurazepam—CYP3A4—Simvastatin—atherosclerosis	0.0434	0.0845	CbGbCtD
Flurazepam—CYP3A4—Lovastatin—atherosclerosis	0.0425	0.0827	CbGbCtD
Flurazepam—CYP3A4—Pravastatin—atherosclerosis	0.0425	0.0827	CbGbCtD
Flurazepam—Upset stomach—Lovastatin—atherosclerosis	0.00908	0.026	CcSEcCtD
Flurazepam—Upset stomach—Simvastatin—atherosclerosis	0.00849	0.0244	CcSEcCtD
Flurazepam—Heartburn—Niacin—atherosclerosis	0.00742	0.0213	CcSEcCtD
Flurazepam—Heartburn—Pravastatin—atherosclerosis	0.00731	0.021	CcSEcCtD
Flurazepam—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.00595	0.0171	CcSEcCtD
Flurazepam—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.00583	0.0167	CcSEcCtD
Flurazepam—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.00556	0.016	CcSEcCtD
Flurazepam—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.00503	0.0144	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.00496	0.0142	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00487	0.014	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.00464	0.0133	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.0042	0.012	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00381	0.0109	CcSEcCtD
Flurazepam—Abdominal discomfort—Lovastatin—atherosclerosis	0.00358	0.0103	CcSEcCtD
Flurazepam—Abdominal discomfort—Simvastatin—atherosclerosis	0.00335	0.0096	CcSEcCtD
Flurazepam—Flushing—Lovastatin—atherosclerosis	0.00277	0.00795	CcSEcCtD
Flurazepam—Sweating—Niacin—atherosclerosis	0.00274	0.00786	CcSEcCtD
Flurazepam—Flushing—Ezetimibe—atherosclerosis	0.00272	0.0078	CcSEcCtD
Flurazepam—Arthralgia—Rosuvastatin—atherosclerosis	0.00261	0.00749	CcSEcCtD
Flurazepam—Flushing—Simvastatin—atherosclerosis	0.00259	0.00744	CcSEcCtD
Flurazepam—Dysgeusia—Lovastatin—atherosclerosis	0.00255	0.00731	CcSEcCtD
Flurazepam—Confusional state—Rosuvastatin—atherosclerosis	0.00252	0.00724	CcSEcCtD
Flurazepam—Vision blurred—Lovastatin—atherosclerosis	0.00245	0.00703	CcSEcCtD
Flurazepam—Dysgeusia—Simvastatin—atherosclerosis	0.00238	0.00683	CcSEcCtD
Flurazepam—Flushing—Niacin—atherosclerosis	0.00238	0.00683	CcSEcCtD
Flurazepam—Flushing—Pravastatin—atherosclerosis	0.00234	0.00673	CcSEcCtD
Flurazepam—Leukopenia—Lovastatin—atherosclerosis	0.00233	0.00668	CcSEcCtD
Flurazepam—Vision blurred—Simvastatin—atherosclerosis	0.00229	0.00658	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00228	0.00655	CcSEcCtD
Flurazepam—Palpitations—Ezetimibe—atherosclerosis	0.00225	0.00647	CcSEcCtD
Flurazepam—Arthralgia—Lovastatin—atherosclerosis	0.00221	0.00635	CcSEcCtD
Flurazepam—Chest pain—Lovastatin—atherosclerosis	0.00221	0.00635	CcSEcCtD
Flurazepam—Anxiety—Lovastatin—atherosclerosis	0.00221	0.00633	CcSEcCtD
Flurazepam—Dyspepsia—Rosuvastatin—atherosclerosis	0.0022	0.00632	CcSEcCtD
Flurazepam—Tension—Niacin—atherosclerosis	0.00219	0.00629	CcSEcCtD
Flurazepam—Leukopenia—Simvastatin—atherosclerosis	0.00218	0.00625	CcSEcCtD
Flurazepam—Chest pain—Ezetimibe—atherosclerosis	0.00217	0.00623	CcSEcCtD
Flurazepam—Arthralgia—Ezetimibe—atherosclerosis	0.00217	0.00623	CcSEcCtD
Flurazepam—Nervousness—Niacin—atherosclerosis	0.00217	0.00622	CcSEcCtD
Flurazepam—Dry mouth—Lovastatin—atherosclerosis	0.00216	0.00621	CcSEcCtD
Flurazepam—Tension—Pravastatin—atherosclerosis	0.00216	0.00619	CcSEcCtD
Flurazepam—Dysgeusia—Pravastatin—atherosclerosis	0.00215	0.00618	CcSEcCtD
Flurazepam—Constipation—Rosuvastatin—atherosclerosis	0.00214	0.00614	CcSEcCtD
Flurazepam—Confusional state—Lovastatin—atherosclerosis	0.00214	0.00614	CcSEcCtD
Flurazepam—Nervousness—Pravastatin—atherosclerosis	0.00214	0.00613	CcSEcCtD
Flurazepam—Dry mouth—Ezetimibe—atherosclerosis	0.00212	0.00609	CcSEcCtD
Flurazepam—Anaphylactic shock—Lovastatin—atherosclerosis	0.00212	0.00609	CcSEcCtD
Flurazepam—Vision blurred—Niacin—atherosclerosis	0.0021	0.00604	CcSEcCtD
Flurazepam—Confusional state—Ezetimibe—atherosclerosis	0.0021	0.00602	CcSEcCtD
Flurazepam—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00208	0.00597	CcSEcCtD
Flurazepam—Vision blurred—Pravastatin—atherosclerosis	0.00207	0.00595	CcSEcCtD
Flurazepam—Arthralgia—Simvastatin—atherosclerosis	0.00207	0.00594	CcSEcCtD
Flurazepam—Chest pain—Simvastatin—atherosclerosis	0.00207	0.00594	CcSEcCtD
Flurazepam—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00206	0.00592	CcSEcCtD
Flurazepam—Anxiety—Simvastatin—atherosclerosis	0.00206	0.00592	CcSEcCtD
Flurazepam—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00205	0.00588	CcSEcCtD
Flurazepam—Anorexia—Lovastatin—atherosclerosis	0.00202	0.0058	CcSEcCtD
Flurazepam—Syncope—Niacin—atherosclerosis	0.002	0.00575	CcSEcCtD
Flurazepam—Confusional state—Simvastatin—atherosclerosis	0.002	0.00574	CcSEcCtD
Flurazepam—Leukopenia—Niacin—atherosclerosis	0.002	0.00574	CcSEcCtD
Flurazepam—Anaphylactic shock—Simvastatin—atherosclerosis	0.00198	0.0057	CcSEcCtD
Flurazepam—Palpitations—Niacin—atherosclerosis	0.00197	0.00566	CcSEcCtD
Flurazepam—Leukopenia—Pravastatin—atherosclerosis	0.00197	0.00565	CcSEcCtD
Flurazepam—Loss of consciousness—Niacin—atherosclerosis	0.00196	0.00563	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00193	0.00555	CcSEcCtD
Flurazepam—Arthralgia—Niacin—atherosclerosis	0.0019	0.00546	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.0019	0.00544	CcSEcCtD
Flurazepam—Anorexia—Simvastatin—atherosclerosis	0.00189	0.00543	CcSEcCtD
Flurazepam—Dyspnoea—Lovastatin—atherosclerosis	0.00189	0.00543	CcSEcCtD
Flurazepam—Chest pain—Pravastatin—atherosclerosis	0.00187	0.00537	CcSEcCtD
Flurazepam—Arthralgia—Pravastatin—atherosclerosis	0.00187	0.00537	CcSEcCtD
Flurazepam—Dyspepsia—Lovastatin—atherosclerosis	0.00187	0.00536	CcSEcCtD
Flurazepam—Anxiety—Pravastatin—atherosclerosis	0.00187	0.00535	CcSEcCtD
Flurazepam—Dry mouth—Niacin—atherosclerosis	0.00186	0.00534	CcSEcCtD
Flurazepam—Dyspnoea—Ezetimibe—atherosclerosis	0.00186	0.00532	CcSEcCtD
Flurazepam—Decreased appetite—Lovastatin—atherosclerosis	0.00184	0.00529	CcSEcCtD
Flurazepam—Dyspepsia—Ezetimibe—atherosclerosis	0.00183	0.00526	CcSEcCtD
Flurazepam—Anaphylactic shock—Niacin—atherosclerosis	0.00182	0.00523	CcSEcCtD
Flurazepam—Constipation—Lovastatin—atherosclerosis	0.00181	0.00521	CcSEcCtD
Flurazepam—Confusional state—Pravastatin—atherosclerosis	0.00181	0.00519	CcSEcCtD
Flurazepam—Decreased appetite—Ezetimibe—atherosclerosis	0.00181	0.00519	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00181	0.00519	CcSEcCtD
Flurazepam—Asthenia—Rosuvastatin—atherosclerosis	0.0018	0.00515	CcSEcCtD
Flurazepam—Anaphylactic shock—Pravastatin—atherosclerosis	0.00179	0.00515	CcSEcCtD
Flurazepam—Shock—Niacin—atherosclerosis	0.00179	0.00514	CcSEcCtD
Flurazepam—Constipation—Ezetimibe—atherosclerosis	0.00178	0.00511	CcSEcCtD
Flurazepam—Pruritus—Rosuvastatin—atherosclerosis	0.00177	0.00508	CcSEcCtD
Flurazepam—Dyspnoea—Simvastatin—atherosclerosis	0.00177	0.00508	CcSEcCtD
Flurazepam—Hyperhidrosis—Niacin—atherosclerosis	0.00176	0.00506	CcSEcCtD
Flurazepam—Feeling abnormal—Lovastatin—atherosclerosis	0.00175	0.00502	CcSEcCtD
Flurazepam—Dyspepsia—Simvastatin—atherosclerosis	0.00175	0.00501	CcSEcCtD
Flurazepam—Anorexia—Niacin—atherosclerosis	0.00174	0.00498	CcSEcCtD
Flurazepam—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00174	0.00498	CcSEcCtD
Flurazepam—Hyperhidrosis—Pravastatin—atherosclerosis	0.00173	0.00498	CcSEcCtD
Flurazepam—Decreased appetite—Simvastatin—atherosclerosis	0.00173	0.00495	CcSEcCtD
Flurazepam—Feeling abnormal—Ezetimibe—atherosclerosis	0.00171	0.00492	CcSEcCtD
Flurazepam—Diarrhoea—Rosuvastatin—atherosclerosis	0.00171	0.00492	CcSEcCtD
Flurazepam—Anorexia—Pravastatin—atherosclerosis	0.00171	0.00491	CcSEcCtD
Flurazepam—Hypotension—Niacin—atherosclerosis	0.0017	0.00489	CcSEcCtD
Flurazepam—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.0017	0.00488	CcSEcCtD
Flurazepam—Constipation—Simvastatin—atherosclerosis	0.0017	0.00487	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00166	0.00476	CcSEcCtD
Flurazepam—Dizziness—Rosuvastatin—atherosclerosis	0.00166	0.00475	CcSEcCtD
Flurazepam—Chloroquine—TNF—atherosclerosis	0.00164	0.347	CrCbGaD
Flurazepam—Feeling abnormal—Simvastatin—atherosclerosis	0.00164	0.00469	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00163	0.00469	CcSEcCtD
Flurazepam—Dyspnoea—Niacin—atherosclerosis	0.00162	0.00466	CcSEcCtD
Flurazepam—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00162	0.00466	CcSEcCtD
Flurazepam—Somnolence—Niacin—atherosclerosis	0.00162	0.00465	CcSEcCtD
Flurazepam—Dyspepsia—Niacin—atherosclerosis	0.0016	0.0046	CcSEcCtD
Flurazepam—Dyspnoea—Pravastatin—atherosclerosis	0.0016	0.00459	CcSEcCtD
Flurazepam—Decreased appetite—Niacin—atherosclerosis	0.00158	0.00455	CcSEcCtD
Flurazepam—Dyspepsia—Pravastatin—atherosclerosis	0.00158	0.00453	CcSEcCtD
Flurazepam—Rash—Rosuvastatin—atherosclerosis	0.00158	0.00453	CcSEcCtD
Flurazepam—Dermatitis—Rosuvastatin—atherosclerosis	0.00158	0.00453	CcSEcCtD
Flurazepam—Headache—Rosuvastatin—atherosclerosis	0.00157	0.0045	CcSEcCtD
Flurazepam—Decreased appetite—Pravastatin—atherosclerosis	0.00156	0.00448	CcSEcCtD
Flurazepam—Constipation—Pravastatin—atherosclerosis	0.00153	0.0044	CcSEcCtD
Flurazepam—Asthenia—Lovastatin—atherosclerosis	0.00152	0.00437	CcSEcCtD
Flurazepam—Pruritus—Lovastatin—atherosclerosis	0.0015	0.00431	CcSEcCtD
Flurazepam—Asthenia—Ezetimibe—atherosclerosis	0.00149	0.00428	CcSEcCtD
Flurazepam—Gastrointestinal pain—Niacin—atherosclerosis	0.00149	0.00428	CcSEcCtD
Flurazepam—Nausea—Rosuvastatin—atherosclerosis	0.00149	0.00427	CcSEcCtD
Flurazepam—Feeling abnormal—Pravastatin—atherosclerosis	0.00148	0.00424	CcSEcCtD
Flurazepam—Pruritus—Ezetimibe—atherosclerosis	0.00147	0.00423	CcSEcCtD
Flurazepam—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00147	0.00421	CcSEcCtD
Flurazepam—Diarrhoea—Lovastatin—atherosclerosis	0.00145	0.00417	CcSEcCtD
Flurazepam—Asthenia—Simvastatin—atherosclerosis	0.00142	0.00409	CcSEcCtD
Flurazepam—Diarrhoea—Ezetimibe—atherosclerosis	0.00142	0.00409	CcSEcCtD
Flurazepam—Pruritus—Simvastatin—atherosclerosis	0.0014	0.00403	CcSEcCtD
Flurazepam—Dizziness—Lovastatin—atherosclerosis	0.0014	0.00403	CcSEcCtD
Flurazepam—Dizziness—Ezetimibe—atherosclerosis	0.00138	0.00395	CcSEcCtD
Flurazepam—Diarrhoea—Simvastatin—atherosclerosis	0.00136	0.0039	CcSEcCtD
Flurazepam—Vomiting—Lovastatin—atherosclerosis	0.00135	0.00387	CcSEcCtD
Flurazepam—Rash—Lovastatin—atherosclerosis	0.00134	0.00384	CcSEcCtD
Flurazepam—Dermatitis—Lovastatin—atherosclerosis	0.00134	0.00384	CcSEcCtD
Flurazepam—Headache—Lovastatin—atherosclerosis	0.00133	0.00381	CcSEcCtD
Flurazepam—Vomiting—Ezetimibe—atherosclerosis	0.00132	0.0038	CcSEcCtD
Flurazepam—Dizziness—Simvastatin—atherosclerosis	0.00131	0.00377	CcSEcCtD
Flurazepam—Rash—Ezetimibe—atherosclerosis	0.00131	0.00377	CcSEcCtD
Flurazepam—Dermatitis—Ezetimibe—atherosclerosis	0.00131	0.00376	CcSEcCtD
Flurazepam—Asthenia—Niacin—atherosclerosis	0.00131	0.00375	CcSEcCtD
Flurazepam—Headache—Ezetimibe—atherosclerosis	0.0013	0.00374	CcSEcCtD
Flurazepam—Pruritus—Niacin—atherosclerosis	0.00129	0.0037	CcSEcCtD
Flurazepam—Asthenia—Pravastatin—atherosclerosis	0.00129	0.00369	CcSEcCtD
Flurazepam—Pruritus—Pravastatin—atherosclerosis	0.00127	0.00364	CcSEcCtD
Flurazepam—Vomiting—Simvastatin—atherosclerosis	0.00126	0.00362	CcSEcCtD
Flurazepam—Nausea—Lovastatin—atherosclerosis	0.00126	0.00362	CcSEcCtD
Flurazepam—Rash—Simvastatin—atherosclerosis	0.00125	0.00359	CcSEcCtD
Flurazepam—Dermatitis—Simvastatin—atherosclerosis	0.00125	0.00359	CcSEcCtD
Flurazepam—Diarrhoea—Niacin—atherosclerosis	0.00125	0.00358	CcSEcCtD
Flurazepam—Headache—Simvastatin—atherosclerosis	0.00124	0.00357	CcSEcCtD
Flurazepam—Nausea—Ezetimibe—atherosclerosis	0.00124	0.00355	CcSEcCtD
Flurazepam—Diarrhoea—Pravastatin—atherosclerosis	0.00123	0.00352	CcSEcCtD
Flurazepam—Dizziness—Niacin—atherosclerosis	0.00121	0.00346	CcSEcCtD
Flurazepam—Chlorprothixene—HRH1—atherosclerosis	0.00119	0.252	CrCbGaD
Flurazepam—Dizziness—Pravastatin—atherosclerosis	0.00119	0.0034	CcSEcCtD
Flurazepam—Nausea—Simvastatin—atherosclerosis	0.00118	0.00338	CcSEcCtD
Flurazepam—Vomiting—Niacin—atherosclerosis	0.00116	0.00332	CcSEcCtD
Flurazepam—Rash—Niacin—atherosclerosis	0.00115	0.0033	CcSEcCtD
Flurazepam—Dermatitis—Niacin—atherosclerosis	0.00115	0.00329	CcSEcCtD
Flurazepam—Headache—Niacin—atherosclerosis	0.00114	0.00328	CcSEcCtD
Flurazepam—Vomiting—Pravastatin—atherosclerosis	0.00114	0.00327	CcSEcCtD
Flurazepam—Rash—Pravastatin—atherosclerosis	0.00113	0.00325	CcSEcCtD
Flurazepam—Dermatitis—Pravastatin—atherosclerosis	0.00113	0.00324	CcSEcCtD
Flurazepam—Headache—Pravastatin—atherosclerosis	0.00112	0.00323	CcSEcCtD
Flurazepam—Nausea—Niacin—atherosclerosis	0.00108	0.00311	CcSEcCtD
Flurazepam—Nausea—Pravastatin—atherosclerosis	0.00107	0.00306	CcSEcCtD
Flurazepam—Chlorpromazine—HRH1—atherosclerosis	0.000822	0.174	CrCbGaD
Flurazepam—Clonazepam—ALB—atherosclerosis	0.000399	0.0844	CrCbGaD
Flurazepam—Clomipramine—ALB—atherosclerosis	0.000277	0.0585	CrCbGaD
Flurazepam—Diazepam—ALB—atherosclerosis	0.000204	0.0432	CrCbGaD
Flurazepam—Chlorpromazine—ALB—atherosclerosis	0.00019	0.0401	CrCbGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.66e-05	0.000426	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—APOB—atherosclerosis	5.63e-05	0.000424	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—ALB—atherosclerosis	5.63e-05	0.000424	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.55e-05	0.000418	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PLTP—atherosclerosis	5.47e-05	0.000412	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—APOA2—atherosclerosis	5.45e-05	0.00041	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PLA2G2A—atherosclerosis	5.45e-05	0.00041	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ALOX5AP—atherosclerosis	5.45e-05	0.00041	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ALOX15—atherosclerosis	5.45e-05	0.00041	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL6—atherosclerosis	5.43e-05	0.000409	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ABCG5—atherosclerosis	5.38e-05	0.000405	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—ALB—atherosclerosis	5.33e-05	0.000401	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP27A1—atherosclerosis	5.28e-05	0.000397	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—ALB—atherosclerosis	5.26e-05	0.000396	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—LPA—atherosclerosis	5.2e-05	0.000391	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.18e-05	0.00039	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	5.13e-05	0.000386	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	5.05e-05	0.00038	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—BGN—atherosclerosis	5.03e-05	0.000379	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ALOX5AP—atherosclerosis	5e-05	0.000377	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—APOA2—atherosclerosis	5e-05	0.000377	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ALOX15—atherosclerosis	5e-05	0.000377	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PLA2G2A—atherosclerosis	5e-05	0.000377	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	5e-05	0.000376	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—APOA5—atherosclerosis	4.98e-05	0.000375	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	4.98e-05	0.000375	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ABCG1—atherosclerosis	4.97e-05	0.000375	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ABCG5—atherosclerosis	4.94e-05	0.000372	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.85e-05	0.000366	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—ALB—atherosclerosis	4.81e-05	0.000362	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PLA2G1B—atherosclerosis	4.8e-05	0.000361	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—LPA—atherosclerosis	4.77e-05	0.000359	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.75e-05	0.000358	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ABCG8—atherosclerosis	4.74e-05	0.000357	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—LTA4H—atherosclerosis	4.74e-05	0.000357	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—LCAT—atherosclerosis	4.68e-05	0.000352	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—FABP4—atherosclerosis	4.68e-05	0.000352	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—ALB—atherosclerosis	4.67e-05	0.000352	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	4.65e-05	0.00035	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ALOX5—atherosclerosis	4.63e-05	0.000349	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—BGN—atherosclerosis	4.62e-05	0.000348	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—APOA4—atherosclerosis	4.59e-05	0.000346	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—ALB—atherosclerosis	4.59e-05	0.000346	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—APOA5—atherosclerosis	4.57e-05	0.000344	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—ALB—atherosclerosis	4.51e-05	0.00034	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP7A1—atherosclerosis	4.51e-05	0.00034	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—ALB—atherosclerosis	4.48e-05	0.000337	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.46e-05	0.000336	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PLA2G1B—atherosclerosis	4.4e-05	0.000332	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—ALB—atherosclerosis	4.4e-05	0.000331	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ALOX5—atherosclerosis	4.25e-05	0.00032	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	4.25e-05	0.00032	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP27A1—atherosclerosis	4.17e-05	0.000314	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—NAMPT—atherosclerosis	4.15e-05	0.000313	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—LIPC—atherosclerosis	4.13e-05	0.000311	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—APOC3—atherosclerosis	4.1e-05	0.000309	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.09e-05	0.000308	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—LDLR—atherosclerosis	4.08e-05	0.000307	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CETP—atherosclerosis	3.98e-05	0.0003	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PLA2G2A—atherosclerosis	3.95e-05	0.000298	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ALOX5AP—atherosclerosis	3.95e-05	0.000298	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—APOA2—atherosclerosis	3.95e-05	0.000298	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ALOX15—atherosclerosis	3.95e-05	0.000298	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ABCG5—atherosclerosis	3.9e-05	0.000294	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—ALB—atherosclerosis	3.85e-05	0.00029	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SCARB1—atherosclerosis	3.81e-05	0.000287	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NAMPT—atherosclerosis	3.81e-05	0.000287	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—LIPC—atherosclerosis	3.79e-05	0.000285	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—LPA—atherosclerosis	3.77e-05	0.000284	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—APOC3—atherosclerosis	3.77e-05	0.000284	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ABCG1—atherosclerosis	3.75e-05	0.000282	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—LDLR—atherosclerosis	3.74e-05	0.000282	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	3.69e-05	0.000278	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CETP—atherosclerosis	3.66e-05	0.000275	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—BGN—atherosclerosis	3.65e-05	0.000275	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	3.63e-05	0.000273	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—APOA5—atherosclerosis	3.61e-05	0.000272	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—HMGCR—atherosclerosis	3.6e-05	0.000271	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	3.58e-05	0.00027	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.53e-05	0.000266	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—LCAT—atherosclerosis	3.52e-05	0.000265	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—FABP4—atherosclerosis	3.52e-05	0.000265	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SCARB1—atherosclerosis	3.5e-05	0.000264	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	3.48e-05	0.000262	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PLA2G1B—atherosclerosis	3.48e-05	0.000262	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—APOA4—atherosclerosis	3.46e-05	0.00026	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP7A1—atherosclerosis	3.4e-05	0.000256	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PLTP—atherosclerosis	3.37e-05	0.000254	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ALOX5—atherosclerosis	3.36e-05	0.000253	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	3.35e-05	0.000252	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—HMGCR—atherosclerosis	3.31e-05	0.000249	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.21e-05	0.000242	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ABCA1—atherosclerosis	3.21e-05	0.000242	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	3.17e-05	0.000239	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP27A1—atherosclerosis	3.14e-05	0.000236	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	3.08e-05	0.000232	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	3.07e-05	0.000231	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NAMPT—atherosclerosis	3.01e-05	0.000227	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—LIPC—atherosclerosis	3e-05	0.000226	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—APOC3—atherosclerosis	2.98e-05	0.000224	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PLA2G2A—atherosclerosis	2.98e-05	0.000224	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—APOA2—atherosclerosis	2.98e-05	0.000224	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ALOX5AP—atherosclerosis	2.98e-05	0.000224	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ALOX15—atherosclerosis	2.98e-05	0.000224	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—LDLR—atherosclerosis	2.96e-05	0.000223	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ABCA1—atherosclerosis	2.95e-05	0.000222	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ABCG5—atherosclerosis	2.94e-05	0.000221	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.92e-05	0.00022	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.92e-05	0.00022	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CETP—atherosclerosis	2.89e-05	0.000218	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	2.87e-05	0.000216	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—LPA—atherosclerosis	2.84e-05	0.000214	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SCARB1—atherosclerosis	2.77e-05	0.000208	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—HMOX1—atherosclerosis	2.75e-05	0.000207	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—BGN—atherosclerosis	2.75e-05	0.000207	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—APOA5—atherosclerosis	2.72e-05	0.000205	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—APOB—atherosclerosis	2.64e-05	0.000199	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PLA2G1B—atherosclerosis	2.62e-05	0.000197	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—HMGCR—atherosclerosis	2.61e-05	0.000197	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.6e-05	0.000195	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTM1—atherosclerosis	2.57e-05	0.000193	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ALOX5—atherosclerosis	2.53e-05	0.000191	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—HMOX1—atherosclerosis	2.53e-05	0.00019	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—LPL—atherosclerosis	2.52e-05	0.00019	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GPX1—atherosclerosis	2.46e-05	0.000185	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.44e-05	0.000183	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—APOB—atherosclerosis	2.42e-05	0.000182	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CD36—atherosclerosis	2.39e-05	0.00018	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTM1—atherosclerosis	2.36e-05	0.000177	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ABCA1—atherosclerosis	2.33e-05	0.000175	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—LPL—atherosclerosis	2.31e-05	0.000174	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.31e-05	0.000174	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NAMPT—atherosclerosis	2.27e-05	0.000171	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—MTHFR—atherosclerosis	2.27e-05	0.000171	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GPX1—atherosclerosis	2.26e-05	0.00017	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—LIPC—atherosclerosis	2.26e-05	0.00017	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—APOC3—atherosclerosis	2.24e-05	0.000169	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—LDLR—atherosclerosis	2.23e-05	0.000168	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PPARA—atherosclerosis	2.23e-05	0.000168	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CD36—atherosclerosis	2.2e-05	0.000165	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CETP—atherosclerosis	2.18e-05	0.000164	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—FABP4—atherosclerosis	2.17e-05	0.000163	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—LCAT—atherosclerosis	2.17e-05	0.000163	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—AGT—atherosclerosis	2.16e-05	0.000162	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.14e-05	0.000161	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—APOA4—atherosclerosis	2.13e-05	0.00016	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—APOE—atherosclerosis	2.11e-05	0.000159	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.09e-05	0.000158	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CAV1—atherosclerosis	2.09e-05	0.000158	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—APOA1—atherosclerosis	2.09e-05	0.000157	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SCARB1—atherosclerosis	2.08e-05	0.000157	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—MTHFR—atherosclerosis	2.08e-05	0.000157	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PPARA—atherosclerosis	2.04e-05	0.000154	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—HMOX1—atherosclerosis	2e-05	0.000151	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—AGT—atherosclerosis	1.98e-05	0.000149	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—HMGCR—atherosclerosis	1.97e-05	0.000148	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—APOE—atherosclerosis	1.94e-05	0.000146	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.93e-05	0.000146	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.93e-05	0.000145	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CAV1—atherosclerosis	1.92e-05	0.000145	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—APOA1—atherosclerosis	1.92e-05	0.000144	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—APOB—atherosclerosis	1.91e-05	0.000144	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PIK3CG—atherosclerosis	1.91e-05	0.000144	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTM1—atherosclerosis	1.86e-05	0.00014	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PPARG—atherosclerosis	1.84e-05	0.000139	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.83e-05	0.000138	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.83e-05	0.000138	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.83e-05	0.000138	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—APOA2—atherosclerosis	1.83e-05	0.000138	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—LPL—atherosclerosis	1.83e-05	0.000138	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.81e-05	0.000136	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—INS—atherosclerosis	1.8e-05	0.000136	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GPX1—atherosclerosis	1.78e-05	0.000134	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ABCA1—atherosclerosis	1.75e-05	0.000132	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PIK3CG—atherosclerosis	1.75e-05	0.000132	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—LPA—atherosclerosis	1.75e-05	0.000132	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CD36—atherosclerosis	1.74e-05	0.000131	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—BGN—atherosclerosis	1.69e-05	0.000128	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PPARG—atherosclerosis	1.69e-05	0.000127	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—APOA5—atherosclerosis	1.68e-05	0.000126	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—INS—atherosclerosis	1.66e-05	0.000125	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ALB—atherosclerosis	1.65e-05	0.000125	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—MTHFR—atherosclerosis	1.65e-05	0.000124	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PPARA—atherosclerosis	1.61e-05	0.000122	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.61e-05	0.000122	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—NOS3—atherosclerosis	1.58e-05	0.000119	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—AGT—atherosclerosis	1.56e-05	0.000118	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.56e-05	0.000117	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—APOE—atherosclerosis	1.53e-05	0.000115	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ALB—atherosclerosis	1.52e-05	0.000114	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CAV1—atherosclerosis	1.52e-05	0.000114	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—APOA1—atherosclerosis	1.51e-05	0.000114	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—HMOX1—atherosclerosis	1.5e-05	0.000113	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NOS3—atherosclerosis	1.45e-05	0.000109	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PTGS2—atherosclerosis	1.45e-05	0.000109	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—APOB—atherosclerosis	1.44e-05	0.000109	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTM1—atherosclerosis	1.4e-05	0.000106	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.4e-05	0.000105	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—LIPC—atherosclerosis	1.39e-05	0.000105	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PIK3CG—atherosclerosis	1.38e-05	0.000104	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—APOC3—atherosclerosis	1.38e-05	0.000104	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—LPL—atherosclerosis	1.38e-05	0.000104	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—LDLR—atherosclerosis	1.37e-05	0.000103	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GPX1—atherosclerosis	1.34e-05	0.000101	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CETP—atherosclerosis	1.34e-05	0.000101	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PPARG—atherosclerosis	1.33e-05	0.0001	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PTGS2—atherosclerosis	1.33e-05	0.0001	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—INS—atherosclerosis	1.31e-05	9.86e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CD36—atherosclerosis	1.31e-05	9.85e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.28e-05	9.67e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—MTHFR—atherosclerosis	1.24e-05	9.33e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PPARA—atherosclerosis	1.22e-05	9.16e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.21e-05	9.13e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ALB—atherosclerosis	1.2e-05	9.04e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—AGT—atherosclerosis	1.18e-05	8.87e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—APOE—atherosclerosis	1.15e-05	8.69e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NOS3—atherosclerosis	1.15e-05	8.64e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CAV1—atherosclerosis	1.14e-05	8.61e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—APOA1—atherosclerosis	1.14e-05	8.59e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.08e-05	8.14e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PTGS2—atherosclerosis	1.05e-05	7.91e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.04e-05	7.84e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PPARG—atherosclerosis	1e-05	7.57e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—INS—atherosclerosis	9.86e-06	7.42e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—HMOX1—atherosclerosis	9.27e-06	6.98e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ALB—atherosclerosis	9.04e-06	6.8e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—APOB—atherosclerosis	8.88e-06	6.69e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NOS3—atherosclerosis	8.64e-06	6.51e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTM1—atherosclerosis	8.64e-06	6.51e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—LPL—atherosclerosis	8.48e-06	6.39e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GPX1—atherosclerosis	8.27e-06	6.23e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CD36—atherosclerosis	8.06e-06	6.07e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PTGS2—atherosclerosis	7.91e-06	5.95e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—MTHFR—atherosclerosis	7.64e-06	5.75e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PPARA—atherosclerosis	7.49e-06	5.64e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—AKT1—atherosclerosis	7.27e-06	5.48e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—AGT—atherosclerosis	7.25e-06	5.46e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—APOE—atherosclerosis	7.11e-06	5.35e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CAV1—atherosclerosis	7.04e-06	5.3e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—APOA1—atherosclerosis	7.03e-06	5.29e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—AKT1—atherosclerosis	6.68e-06	5.03e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PIK3CG—atherosclerosis	6.42e-06	4.83e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PPARG—atherosclerosis	6.19e-06	4.66e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—INS—atherosclerosis	6.07e-06	4.57e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ALB—atherosclerosis	5.57e-06	4.19e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NOS3—atherosclerosis	5.33e-06	4.01e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—AKT1—atherosclerosis	5.28e-06	3.97e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.87e-06	3.67e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—AKT1—atherosclerosis	3.97e-06	2.99e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—AKT1—atherosclerosis	2.45e-06	1.84e-05	CbGpPWpGaD
